Zobrazeno 1 - 10
of 162
pro vyhledávání: '"MARIO CALVO A"'
Autor:
Matias A Medina, Francisco Fuentes-Villalobos, Claudio Quevedo, Felipe Aguilera, Raul Riquelme, Maria Luisa Rioseco, Sebastian Barria, Yazmin Pinos, Mario Calvo, Ian Burbulis, Camila Kossack, Raymond A Alvarez, Jose Luis Garrido, Maria Ines Barria
Publikováno v:
eLife, Vol 13 (2024)
Patients present a wide range of clinical severities in response severe acute respiratory syndrome coronavirus 2 infection, but the underlying molecular and cellular reasons why clinical outcomes vary so greatly within the population remains unknown.
Externí odkaz:
https://doaj.org/article/2c2dd94d3b154690b6da75992e85ea7a
Autor:
Wanqi Yang, Pablo A. González, Qianqian Xin, Mari Rose De Los Reyes, Ralph Elvi Villalobos, Charissa Fay Corazon Borja-Tabora, Nancy Nazaire Bermal, Alexis M. Kalergis, Dan Yu, Wenbin Wu, Susan M. Bueno, Liqun Huo, Mario Calvo, QINF Study Group, Gang Zeng, Jing Li
Publikováno v:
Vaccines, Vol 12, Iss 8, p 892 (2024)
Objectives: In this study, we aimed to evaluate the non-inferiority of a quadrivalent influenza vaccine (QIV) developed by Sinovac Biotech Co., Ltd. (Sinovac, Beijing, China) by comparing its immunogenicity and safety with a comparator QIV (Vaxigrip
Externí odkaz:
https://doaj.org/article/30862a675efc4d33bbc8f896b755ecee
Autor:
Analía Urueña, Ricardo Machado, Juarez Cunha, Clara López Colmano, Carolina Rancaño, Renato Kfouri, Catalina Pírez, Pablo Bonvehí, Mario Calvo, Robinson Cuadros, Greta Muñoz, Mónica Rodríguez, Jaime Torres, Florencia Cahn, Isabella Ballalai
Publikováno v:
Vaccines, Vol 11, Iss 11, p 1660 (2023)
This article presents attitudes and practices regarding COVID-19 vaccination in the South American population. The study collected data from a self-administered survey distributed through social media platforms between February and April 2022 (N = 65
Externí odkaz:
https://doaj.org/article/92f97a0c775e453e9dd97299b1a9ec5e
Autor:
Jorge A. Soto, Felipe Melo-González, Cristián Gutierrez-Vera, Bárbara M. Schultz, Roslye V. Berríos-Rojas, Daniela Rivera-Pérez, Alejandro Piña-Iturbe, Guillermo Hoppe-Elsholz, Luisa F. Duarte, Yaneisi Vázquez, Daniela Moreno-Tapia, Mariana Ríos, Pablo A. Palacios, Richard Garcia-Betancourt, Álvaro Santibañez, Gaspar A. Pacheco, Constanza Mendez, Catalina A. Andrade, Pedro H. Silva, Benjamín Diethelm-Varela, Patricio Astudillo, Mario Calvo, Antonio Cárdenas, Marcela González, Macarena Goldsack, Valentina Gutiérrez, Marcela Potin, Andrea Schilling, Lorena I. Tapia, Loreto Twele, Rodolfo Villena, Alba Grifoni, Alessandro Sette, Daniela Weiskopf, Rodrigo A. Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Aracelly Gaete-Argel, Mónica L. Acevedo, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Angello Retamal-Díaz, Nathalia Muñoz-Jofré, Xing Meng, Qianqian Xin, Eduardo Alarcón-Bustamante, José V. González-Aramundiz, Nicole Le Corre, María Javiera Álvarez-Figueroa, Pablo A. González, Katia Abarca, Cecilia Perret, Leandro J. Carreño, Susan M. Bueno, Alexis M. Kalergis
Publikováno v:
mBio, Vol 13, Iss 6 (2022)
ABSTRACT Multiple vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been evaluated in clinical trials. However, trials addressing the immune response in the pediatric population are scarce. The inactivated vaccine Cor
Externí odkaz:
https://doaj.org/article/cf113e0121754f51995644752d348004
Autor:
Nicole Le Corre, Katia Abarca, Patricio Astudillo, Marcela Potin, Sofía López, Macarena Goldsack, Vania Valenzuela, Andrea Schilling, Victoria Gaete, Lilian Rubio, Mario Calvo, Loreto Twele, Marcela González, Daniela Fuentes, Valentina Gutiérrez, Felipe Reyes, Lorena I. Tapia, Rodolfo Villena, Angello Retamal-Díaz, Antonio Cárdenas, Eduardo Alarcón-Bustamante, Xing Meng, Qianqian Xin, José V. González-Aramundiz, María Javiera Álvarez-Figueroa, Pablo A. González, Susan M. Bueno, Jorge A. Soto, on behalf of the PedCoronaVac03CL Study Group, Cecilia Perret, Alexis M. Kalergis
Publikováno v:
Vaccines, Vol 11, Iss 10, p 1526 (2023)
During the COVID-19 pandemic, the importance of vaccinating children against SARS-CoV-2 was rapidly established. This study describes the safety of CoronaVac® in children and adolescents between 3- and 17-years-old in a multicenter study in Chile wi
Externí odkaz:
https://doaj.org/article/c5022dfe2bd44e14b220236ff2479bce
Autor:
René López, Mauricio Espinoza, Jerónimo Graf, Gregory Mertz, Marcela Ferrés, Mario Calvo, Cecilia Vial, Pablo A. Vial
Publikováno v:
International Journal of Infectious Diseases, Vol 110, Iss , Pp 466-468 (2021)
Objectives: To determine the relative frequency and prognosis value of proteinuria in hantavirus cardiopulmonary syndrome (HCPS) due to Andes virus. Methods: This observational analytical study prospectively obtained data from patients admitted to 12
Externí odkaz:
https://doaj.org/article/b0bc71269d0c49809eefee8ed68b8694
Autor:
Francisco Fuentes-Villalobos, Jose L. Garrido, Matías A. Medina, Nicole Zambrano, Natalia Ross, Felipe Bravo, Aracelly Gaete-Argel, Aarón Oyarzún-Arrau, Fatima Amanat, Ricardo Soto-Rifo, Fernando Valiente-Echeverría, Renato Ocampo, Christian Esveile, Leonila Ferreira, Johanna Cabrera, Vivianne Torres, Maria L. Rioseco, Raúl Riquelme, Sebastián Barría, Raymond Alvarez, Yazmín Pinos, Florian Krammer, Mario Calvo, Maria I. Barria, COVID-19 South Chile Group
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The coronavirus disease 2019 (COVID19) pandemic has left researchers scrambling to identify the humoral immune correlates of protection from COVID-19. To date, the antibody mediated correlates of virus neutralization have been extensively studied. Ho
Externí odkaz:
https://doaj.org/article/841c858572f848e3a2a9466a6ca7be7b
Autor:
Tybbysay P. Salinas, Jose L. Garrido, Jacqueline R. Salazar, Publio Gonzalez, Nicole Zambrano, Francisco Fuentes-Villalobos, Felipe Bravo, Victor Fica-Leon, Alexis Salas-Burgos, Mario Calvo, Raymond Alvarez, Blas Armien, Maria Ines Barria
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundNew World Hantaviruses (NWHs) are the etiological agent underlying hantavirus cardiopulmonary syndrome (HCPS), a severe respiratory disease with high mortality rates in humans. In Panama, infections with Choclo Orthohantavirus (CHOV) cause
Externí odkaz:
https://doaj.org/article/f65cb2e9a3b0485aaf7e5e45a9bb202f
Autor:
Farides Saavedra, Jose L. Garrido, Francisco Fuentes-Villalobos, Mario Calvo, Raúl Riquelme, María Luisa Rioseco, Carolina Chahín, Leonila Ferreira, Raymond Alvarez, Estefania Nova-Lamperti, Maria Ines Barria
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 10 (2020)
Hantavirus cardiopulmonary syndrome (HCPS) caused by Andes orthohantavirus (ANDV) in South America is a public health threat due to the significant rate of mortality and the lack of a specific treatment. Interestingly, the virus does not produce cyto
Externí odkaz:
https://doaj.org/article/50b359cc30c944a69b2938341f5773af
Autor:
Juan Francisco Prieto, Mario Calvo, Celia Gómez, Edgar Fernández, Francisco Javier Pardilla, Eukene Rojo, Cristina Rubín, José Andrés Moreno, Cecilio Santander, Pablo Miranda
Publikováno v:
44 Congreso de la Sociedad Española de Endoscopia Digestiva Abstracts Publication.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8bd72e3c5d521c6710925d51e3fc9e55
https://doi.org/10.48158/seed2022.p086
https://doi.org/10.48158/seed2022.p086